Blinatumomab Combined With Low-dose DLI as Maintenance Therapy After Transplantation for B-ALL

NCT07677878 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

ALL (Acute B-Lymphoblastic Leukemia)

Interventions

DRUG: Blinatumomab Injection
OTHER: Donor Lymphocyte Infusion (DLI)

Sponsor

Liping Dou